Illness understanding and religiousness in patients with recurrent glioblastoma.

IF 2.4 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2024-08-06 eCollection Date: 2025-02-01 DOI:10.1093/nop/npae068
John T Fortunato, Leah E Walsh, Laura C Polacek, Anne S Reiner, Tobias Walbert, Alissa A Thomas, Justin Buthorn, Allison Sigler, Holly G Prigerson, Allison J Applebaum, Eli L Diamond
{"title":"Illness understanding and religiousness in patients with recurrent glioblastoma.","authors":"John T Fortunato, Leah E Walsh, Laura C Polacek, Anne S Reiner, Tobias Walbert, Alissa A Thomas, Justin Buthorn, Allison Sigler, Holly G Prigerson, Allison J Applebaum, Eli L Diamond","doi":"10.1093/nop/npae068","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with glioblastoma (GBM) often have inaccurate perceptions of prognosis. Strong religious beliefs have been associated with limited illness understanding (IU) in patients with advanced cancer, but IU and religiousness have not been investigated in patients with GBM. The aim of this study was to evaluate the association between religiousness and spirituality and IU in patients with GBM.</p><p><strong>Methods: </strong>Patients enrolled in a prospective multicenter study of recurrent GBM (Coping with Glioblastoma, NCT02375841). Within one month of medical visits discussing MRI scans showing GBM progression, patients completed study surveys containing published measures of IU and religiousness. IU was compared between participants with moderate or high versus slight or no religiousness based on several patient-reported prompts using Fisher's exact tests.</p><p><strong>Results: </strong>Twenty-four patients completed surveys of religiousness and IU. IU was partial within our cohort. Fifteen participants (62.5%) acknowledged that their illness was terminal. Only 6 (25%) correctly acknowledged their prognosis (months). Eleven patients (46%) were moderately or very religious, while 9 (38%) were either slightly religious or not at all religious. High religiousness and spirituality were each associated with partial IU (<i>P</i> = .06 and <i>P</i> = .01, respectively). A belief that God could perform a miracle to cure them of cancer and a belief in sanctity through suffering were also each associated with partial IU.</p><p><strong>Conclusions: </strong>This prospective study that suggests religiousness, including the belief in miracles and a belief in sanctification through suffering, might influence patients' IU. Further research is warranted to study this association.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"12 1","pages":"100-112"},"PeriodicalIF":2.4000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798605/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with glioblastoma (GBM) often have inaccurate perceptions of prognosis. Strong religious beliefs have been associated with limited illness understanding (IU) in patients with advanced cancer, but IU and religiousness have not been investigated in patients with GBM. The aim of this study was to evaluate the association between religiousness and spirituality and IU in patients with GBM.

Methods: Patients enrolled in a prospective multicenter study of recurrent GBM (Coping with Glioblastoma, NCT02375841). Within one month of medical visits discussing MRI scans showing GBM progression, patients completed study surveys containing published measures of IU and religiousness. IU was compared between participants with moderate or high versus slight or no religiousness based on several patient-reported prompts using Fisher's exact tests.

Results: Twenty-four patients completed surveys of religiousness and IU. IU was partial within our cohort. Fifteen participants (62.5%) acknowledged that their illness was terminal. Only 6 (25%) correctly acknowledged their prognosis (months). Eleven patients (46%) were moderately or very religious, while 9 (38%) were either slightly religious or not at all religious. High religiousness and spirituality were each associated with partial IU (P = .06 and P = .01, respectively). A belief that God could perform a miracle to cure them of cancer and a belief in sanctity through suffering were also each associated with partial IU.

Conclusions: This prospective study that suggests religiousness, including the belief in miracles and a belief in sanctification through suffering, might influence patients' IU. Further research is warranted to study this association.

复发性胶质母细胞瘤患者的疾病认识与宗教信仰。
背景:胶质母细胞瘤(GBM)患者往往对预后有不准确的认识。强烈的宗教信仰与晚期癌症患者的有限疾病理解(IU)有关,但尚未对GBM患者的IU和宗教信仰进行调查。本研究的目的是评估GBM患者的宗教信仰和灵性与IU之间的关系。方法:患者参加了一项复发性GBM(应对胶质母细胞瘤,NCT02375841)的前瞻性多中心研究。在一个月的医疗访问中,讨论MRI扫描显示GBM进展,患者完成研究调查,包括公布的IU和宗教信仰的测量。采用Fisher精确的测试方法,根据几个患者报告的提示,比较了中度或高程度的受试者与轻度或无宗教信仰的受试者之间的IU。结果:24例患者完成了宗教信仰和IU调查。IU在我们的队列中是局部的。15名参与者(62.5%)承认他们的疾病已经到了晚期。仅有6例(25%)患者正确确认预后(月)。11名患者(46%)中度或非常信教,9名患者(38%)轻微信教或完全不信教。高度的宗教性和精神性与部分IU相关(P =。P =。分别为01)。相信上帝能创造奇迹治愈他们的癌症,以及相信通过苦难获得圣洁,也都与部分IU有关。结论:这项前瞻性研究表明,宗教信仰,包括对奇迹的信仰和对通过苦难成圣的信仰,可能会影响患者的IU。进一步研究这种关联是有必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信